Skip to main content
OpenTrials

Clinical trial condition

Blood Platelet Disorders

Explore clinical trials studying Blood Platelet Disorders. Study availability and eligibility vary by location and protocol.

957 public trials 209 recruiting studies
Refine in advanced search Browse all conditions

Blood Platelet Disorders trial results

Completed

Phase III Study on HMPL-523 for Treatment of ITP

NCT05029635

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The First Affiliated hospital of USTC Hefei, Anhui, China
  • Beijing Chaoyang Hospital of Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 37 locations
View Trial Details
Completed

Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003)

NCT04254978

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Local Institution Jacksonville, Florida, United States
  • Local Institution Ann Arbor, Michigan, United States
  • Local Institution New York, United States
  • Local Institution Durham, North Carolina, United States
View all 26 locations
View Trial Details
Completed

Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma

NCT04673266

Conditions
Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +3 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activites) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Completed

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

NCT04225156

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010037 Ocala, Florida, United States
  • Investigator Site 0010042 Iowa City, Iowa, United States
  • Investigator Site 0010040 Columbus, Ohio, United States
View all 87 locations
View Trial Details

Related conditions